Illustration: Annelise Capossela/Axios
A growing cohort of clinical AI companies is seeking to shape how doctors review medical literature and diagnose patients — and capital is following.
Zoom in: Two companies in the sector have made recent headlines as they seek to gain further traction in an expensive race.
